CPC A61K 47/6855 (2017.08) [A61K 47/6803 (2017.08); A61K 47/6889 (2017.08); C07K 16/2878 (2013.01); C07K 16/32 (2013.01); C12P 21/00 (2013.01); C07K 2317/24 (2013.01); C07K 2317/41 (2013.01)] | 31 Claims |
1. An antibody conjugate comprising
a) one or more linker constructs comprising a linker having the peptide structure (shown in N->C direction):
and
b) an antibody comprising at least one Gln residue (Q295) at position 295 (EU numbering) of the CH2 domain of the antibody, wherein the antibody is N-glycosylated in position N297 (EU numbering) of the CH2 domain;
wherein:
m is an integer between ≥0 and ≤12;
n is an integer between ≥0 and ≤12;
o is an integer between ≥0 and ≤12;
m+n+o is an integer between ≥1 and ≤12;
Aax is any naturally or non-naturally occurring L- or D-amino acid, or amino acid derivative or mimetic;
is a lysine or a lysine derivative or a lysine mimetic having a primary amine group;
B is a payload or a linking moiety
and wherein:
the linker construct is conjugated to the Gln residue Q295 of the CH2 domain of the antibody via the primary amine group of
|